Found 407 matching trials
A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product N/A The primary purpose of this study is to monitor potential long-term risks a...
Show More Status
Enrolling By Invitation
Location
Colorado Blood Cancer Institute, part of Sarah Cannon Research Institute
Learn More & Join Trial
BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B-ALL PHASE1 In this single-center, single-arm, prospective, Phase 1/2 study, the safety...
Show More Learn More & Join Trial
Clinical Study of SL19+22 CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma NA To evaluate the safety and efficacy of SL19+22 in patients with relapsed or...
Show More Location
Hebei Yanda Ludaopei Hospital
Learn More & Join Trial
Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease EARLY_PHASE1 This is an exploratory, open-label, single-arm Phase 1 clinical study desig...
Show More Location
Children's Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell Malignancies PHASE1 This is a global, open-label, multi-arm, parallel multi-cohort, multi-cente...
Show More Location
Local Institution - 011
Learn More & Join Trial
Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer PHASE1 This phase I trial studies the side effects and best dose of autologous CD8...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
CD19 CAR T-cell Target Relapsed/Refractory Acute B Cell Leukemia/Lymphoma PHASE1 This study aims to evaluate the safety and efficacy of humanized Anti-CD19 ...
Show More Location
Guangdong Zhaotai Cell Bio-tech Co., LTD
Learn More & Join Trial
TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia NA This is a clinical study of TAA6 cell injection in the treatment of patient...
Show More Location
Anhui Provincial Hospital
Learn More & Join Trial
Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin PHASE1 The purpose of this Phase I study is to test the safety of different doses ...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up)
Learn More & Join Trial
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma PHASE1 The purpose of this study is to learn whether it is safe to give HER2-CAR T...
Show More Location
Texas Children's Hospital
Learn More & Join Trial